0
Education, Teaching, and Quality Improvement |

Proton Pump Inhibitors vs. H 2 Blockers for Stress Ulcer Prophylaxis in ICU Patients: A Single Center, Retrospective Study of Comparative Outcomes of Clinical Efficacy and Adverse Effects

Kashmira Singh, MD; James Walsh, MD
Author and Funding Information

Robert Packer Hospital/Guthrie Clinic, Sayre, PA


Chest. 2013;144(4_MeetingAbstracts):537A. doi:10.1378/chest.1704924
Text Size: A A A
Published online

Abstract

SESSION TITLE: Cost and Quality Posters

SESSION TYPE: Original Investigation Poster

PRESENTED ON: Wednesday, October 30, 2013 at 01:30 PM - 02:30 PM

PURPOSE: There remains conflicting evidence with limited data regarding the definite superiority of Proton Pump Inhibitors (PPI) over H 2 blockers in stress ulcer prophylaxis. More recent evidence suggests an association of PPI usage with undesirable clinical effects such as higher incidence of clostridium difficile diarrhea and ventilator associated pneumonia (VAP). In light of this evidence, coupled with higher costs associated with PPI use, we have retrospectively compared clinical outcomes in patients treated with a commonly used H2 Blocker; famotidine to patients treated with pantoprazole in an ICU setting.

METHODS: Institutional Review Board approval was obtained. We retrospectively analyzed data from 98 patients admitted to the ICU of a tertiary community hospital. Patients were divided into two groups as per the drug for stress ulcer prophylaxis: group 1: PPI group (n=48) and group 2: H2 blocker group (n=48) Following parameters were compared between the two groups using Fisher’s exact test: 1. Occurrence of gastrointestinal bleed. 2. Occurrence of clostridium difficile diarrhea. 3. Occurrence of ventilator associated pneumonia.

RESULTS: : The comparison of data showed that the incidence of gastrointestinal bleed was similar in both the groups (p=1). Also there was no statistically significant difference in the incidence of clostridium difficile diarrhea (p= 0.644) and ventilator associated pneumonia (p=0.778) in between the groups.

CONCLUSIONS: In this single center, observational study in a tertiary community hospital there was no significant difference in the incidence of gastrointestinal bleed, clostridium difficile diarrhea and ventilator associated pneumonia in ICU patients on PPI vs. those on H 2 blockers for stress ulcer prophylaxis.

CLINICAL IMPLICATIONS: Understanding the efficacy and adverse outcomes of stress ulcer prophylaxis agents will guide physicians to make a cost effective choice in managing critically ill patients and also validates the need for prospective trials comparing the same.

DISCLOSURE: The following authors have nothing to disclose: Kashmira Singh, James Walsh

No Product/Research Disclosure Information


Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543